Synthesis of novel 1-pyrazolylpyridin-2-ones as potential anti-inflammatory and analgesic agents

Archiv der Pharmazie

Volumn 340, Issue 9, 2007, Pages 476-482

  Ismail, Magda M F ^a   Ammar, Yousry A ^b   El Zahaby, Heba S A ^a   Eisa, Sally I ^a   Barakat, Saber El Sayed ^a  

^a Al Azhar University   (Egypt)

^b Al Azhar University   (Egypt)

Author keywords

1 Pyrazolylpyridin 2 one; Analgesic activities; Anti inflammatory; Condensed pyridone

Indexed keywords

1,5 DIMETHYL 4 [2 CYANO 3 (4 METHOXYPHENYL) ACRYLAMIDO] 2 PHENYL 3 (1H) PYRAZOLONE; 3 CYANO 1 (1,5 DIMETHYL 2 PHENYL 3(1H) PYRAZOLON 4 YL) 4[(2 DIMETHYLAMINO)VINYL] 6 METHYL 2(1H) PYRIDONE; 6 AMINO 3,5 DICYANO 1 (1,5 DIMETHYL 2 PHENYL 3(1H) PYRAZOLON 4 YL) 4 METHYL 2(1H) PYRIDONE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; INDOMETACIN; PYRIDONE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROSCOPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FEMALE; MALE; PAIN; PYRIDONES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34748826325     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200600197     Document Type: Article

References (17)

1. H. A. Al-Khamees, S. M. Bayomi, H. A. Kandil, K. E. H. El-Tahir, Eur. J. Med. Chem. 1990, 25, 103-106.
2. F. Manna, F. Chimenti, A. Bolasco, A. Filippelli, et al., Eur. J. Med. Chem. 1992, 27, 627-632.
3. I. V. Ukrainets, P. A. Bezuglyi, V. I. Treskach, M. Y. Kornilov, et al., Khim. Geterotsiki, Soedin 1992, 8, 1086.
4. A. R. Todeschini, A. L. P Miranda, C. M. Silvak, S. C. Parrini, E. J. Barreiro, Eur. J. Med. Chem. 1998, 33, 189-199.
5. H. Sladowska, M. Sieklucka, G. Rajtar, M. Sadowski, Z. Kleinrok, Farmaco 1999, 54, 773-779.
6. H. Sladowska, A. Sabiniarz, B. Filipek, M. Kardasz, M. Derota, Farmaco 2003, 58, 25-32.
7. A. M. Hussein, S. M. Sherif, A. A. Atalla, Monatshefte für Chemie 1996, 127.
8. M. M. F. Ismail, E. Noaman, Med. Chem. Res. 2005, 14, 382-403.
9. Y. A. Ammar, M. M. F. Ismail, H. M. El-Sehrawi, E. Noaman, et al., Arch. Pharm. Chem. Life Sci. 2006, 339, 429-436.
10. A. M. Farag, K. M. Dawood, H. A. El-Menoufy, Heteroatom Chem. 2004, 15, 508-514.
11. A. Seoane, L. Jose, P. Zamorano, J. Heterocyl. Chem. 1981, 18, 309-314.
12. Y. W. Ho, I. J. Wang, J. Heterocyl. Chem. 1995, 32, 819-825.
13. M. A. Al-Shiekh, A. M. Salah El-Din, E. A. Hafez, M. H. El-Nagdi J. Chem. Res. 2004, 3, 174-179.
14. rd Ed., 1956, p. 434.
15. C. A. Winter, E. A. Risly, G. W. Nuss, Proc. Soc. Exp. Biol. Med. 1962, 111, 544-547.
16. P. A. J. Janssen, A. H. Jageneau, E. G. Van, J. H. A. Proosdi, D. K. DeJngh, Acta. Physiol. Et. Pharmacol. Nearl. 1958, 7, 373-402.
17. th Ed., Louis State University Press, Ames, Iowa, USA, 1989.